Evidence mounts for need to study Pfizer's Paxlovid for long COVID - researchers say
Three new case studies follow earlier reports of long COVID patients who experienced relief of their symptoms after taking the treatment
Stay updated with breaking news from Steven Deeks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Three new case studies follow earlier reports of long COVID patients who experienced relief of their symptoms after taking the treatment
CHICAGO — Additional reports of patients with long covid who were helped by Pfizer Inc's oral antiviral treatment Paxlovid offer fresh impetus for conducting clinical trials to test the medicine for the debilitating condition, US researchers said on Thursday (May 5). Three new case studies follow earlier reports of long covid patients who experienced relief of their symptoms after taking...
By Julie Steenhuysen CHICAGO (Reuters) - Additional reports of patients with long COVID who were helped by Pfizer Inc's oral antiviral treatment Paxlo...
CHICAGO - Reports of two patients who found relief from long Covid after taking Pfizer Inc's antiviral Paxlovid, including a researcher who tested it on herself, provide intriguing evidence for clinical trials to help those suffering from the debilitating condition, experts and advocates say. The researcher said her chronic fatigue symptoms, which "felt like a truck hit me," are gone...
The eventual answers to these Covid mysteries will determine our relationship with Covid and and how we'll fight a future pandemic.